You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
16 March 2020
Stada’s Branded Products division reported sales up by 13% to EUR1.07 billion (USD1.16 billion) in 2019, despite falling sales in Russia.
5 March 2020
Stada says it is now the “clear market leader in Russia’s consumer healthcare sector” following recent acquisitions. The German company has just recruited Sandoz’ Stephan Eder as executive vice president of its business in Russia and the Commonwealth of Independent States (CIS).
24 February 2020
Germany’s Stada is strengthening its consumer healthcare presence in Europe by acquiring 15 brands – including Venoruton, Coldrex and Cetebe – from GlaxoSmithKline. The deal follows a series of acquisitions by Stada involving consumer healthcare assets.
12 February 2020
Germany’s Stada is strengthening its consumer healthcare presence in the Asia-Pacific region by acquiring the FERN C product portfolio in the Philippines for an undisclosed sum. The deal follows a series of European acquisitions by Stada.
12 February 2020
Stada has hired Aidan Fry – one of the driving forces behind the creation of the Generics Bulletin newsletter – as director of external communications.
3 February 2020
Bayer, Glanbia, Stada, Diapharm and the US Council for Responsible Nutrition (CRN) have recently announced people changes.
6 December 2019
Germany’s Stada is acquiring the pharmaceutical and consumer healthcare business of Ukrainian company Biopharma, including its probiotic products, for an undisclosed sum.
5 November 2019
Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.
4 November 2019
Stada Arzneimittel is boosting its consumer healthcare presence in Europe by acquiring Czech firm Walmark from private-equity firm Mid Europa Partners.
9 October 2019
The US dietary supplement industry wants rapid action on cannabidiol (CBD) products, Probi has revised its 2019 sales forecast and Thornton & Ross is expanding its capacity.